GENE ONLINE|News &
Opinion
Blog

Regulatory
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
The U.S. COVID-19 Public Health Emergency Ends in May, but FDA’s EUA Authority Remains
2023-02-01
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Biden Administration Outlines Drug Price Negotiation Plan to Take Effect in 2026
2023-01-12
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Retail Pharmacies Can Dispense Abortion Pills Under New FDA Ruling
2023-01-05
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
1 2 3 47
LATEST
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scientists Use iPSCs to Grow Mature Neurons to Study Neurodegenerative Diseases
2023-02-02
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!